New suicidal thoughts, severe agitation or a marked change toward unusually elevated mood needs prompt clinical assessment. Use local emergency services if there is immediate danger or you cannot stay safe.
Medication is one part of depression care, not a complete description of treatment. Choosing whether to use it, deciding which medicine to try and reviewing what happens are separate decisions. This guide explains the main conversations behind those decisions and connects them with the individual medicine profiles in the A-Z library.
Start with assessment, not a list of tablets
Persistent low mood, reduced interest, sleep changes and difficulty functioning can have different explanations. A clinician considers symptoms, their duration, previous episodes, physical health and other medicines or substances. Assessment should also explore any history of unusually elevated or irritable mood, because bipolar disorder requires a different treatment discussion. [1]
Describe the change in ordinary life: what has become difficult, what you have stopped doing and which responsibilities feel impossible. Include what others have noticed, with your consent. Avoid treating a questionnaire score or an internet description as a diagnosis. The purpose of assessment is to understand the situation well enough to agree on a useful and safe plan.
When might medication be part of care?
Depression treatment can involve psychotherapy, medication or both. The choice depends on severity, previous treatment, preferences and the wider clinical situation. For milder depression, psychological treatment may be considered first; more severe presentations often involve medication within an initial plan. These are broad patterns rather than instructions for a particular person. [1]
Ask why a proposed option fits your needs now. What benefit is expected? What alternatives were considered? What support will be available while treatment is starting? You should be able to discuss concerns about medication without being asked to prove that you are sufficiently motivated. Equally, taking an antidepressant does not mean psychological care or practical support is unnecessary.
Understanding the main antidepressant classes
Antidepressants include SSRIs, SNRIs, tricyclic medicines, MAO inhibitors and other medicines with different actions. Commonly used examples in this library include sertraline, escitalopram, duloxetine, venlafaxine and mirtazapine. Class membership helps organize information but does not make products interchangeable. [2]
The more useful question is not which class sounds strongest. Ask how the particular medicine’s expected benefit, tolerability, interaction profile and practical instructions fit the proposed treatment goal. A class label does not capture every difference between products, and a brand familiar from another country may refer to a different formulation or local prescribing context.
What influences the choice of medicine?
Previous response matters, but it needs to be described accurately. Did an earlier medicine provide no benefit despite a reviewed course, or was it stopped because of side effects, access problems or an unclear plan? Bring that distinction to the appointment. NIMH notes that people respond differently and that finding a helpful approach can require more than one treatment attempt. [2]
Also explain your priorities. Perhaps daytime alertness, sexual functioning, appetite, sleep or being able to manage a daily routine is particularly important. These priorities do not dictate a prescription by themselves, but they make shared decision-making more concrete. Ask the clinician which tradeoffs are most relevant and which concerns should be revisited early.
Setting realistic treatment expectations
Antidepressants generally take time to provide their full effect. Changes in sleep, appetite or concentration may precede a clear improvement in mood, and an early unwanted effect is not the same measure as therapeutic benefit. A review should consider the whole pattern rather than one isolated symptom. [1]
Agree on what progress would look like in daily life. For one person, that might be returning to regular meals and personal care; for another, it may be reconnecting with friends or managing a working day. Keep goals achievable and reviewable. Do not interpret a difficult morning as proof of failure, but do not delay reporting significant deterioration because you were told that improvement takes time.
Side effects should remain part of the conversation
Antidepressants can cause unwanted effects involving digestion, sleep, alertness and sexual functioning, among other concerns. The pattern varies between medicines and people. Some effects lessen; others persist and deserve reassessment. Use the individual product information and a pharmacist or prescriber rather than assuming that a general class list explains every new symptom. [2]
Record the practical burden. Is nausea preventing meals? Is tiredness making it difficult to drive or attend appointments? Has intimacy changed in a way that is distressing? These are legitimate treatment outcomes. Ask what information to collect and when the issue should be reviewed. The answer should not automatically be that every adverse effect must be accepted indefinitely.
Monitoring mood changes and urgent concerns
New suicidal thoughts, severe agitation or a marked change toward unusually elevated mood needs prompt attention. Monitoring is especially important after starting treatment or changing a prescription. Immediate danger requires local emergency help rather than waiting for a routine appointment. A general information page cannot judge whether someone is safe. [2]
Before treatment starts, ask whom to contact if you feel worse. Write down the routine contact and the urgent-care route separately. With your agreement, someone you trust can help notice changes and support getting assistance. This is not a replacement for professional follow-up, and it should respect your preferences and privacy wherever possible.
What happens when treatment has not helped enough?
A treatment review should revisit the diagnosis, actual medicine use, tolerability, duration, other health conditions and the support surrounding the prescription. Depending on the assessment, options may include a different medicine, a combination approach, a psychological treatment or specialist care. NIMH also describes brain-stimulation treatment for selected situations where other approaches have not been sufficient. [1]
Ask what the clinician means by an adequate treatment trial in your case and which barriers might explain the experience. A missed supply, intolerable effect or unrecognized co-occurring condition is not the same as a medicine providing no benefit despite consistent use. Keep a record of previous treatments so that the next consultation does not simply repeat an approach without understanding why it ended.
Specialist options need a separate explanation
Some depression treatment plans involve specialist-supervised interventions rather than a routine daily prescription. The esketamine guide introduces one example, including the distinction between supervised administration and self-treatment. The existence of a specialist option does not establish its suitability for every person or its availability through Cogniful.
Ask which indication is being considered, what evidence supports it, what monitoring is required and who will provide follow-up. Discuss alternatives and practical burdens, including travel and time away from work or family. A treatment should be assessed by its relevant evidence and fit with your needs, not by novelty, publicity or a promise of rapid transformation.
Depression and alcohol or other substance use
Tell the clinical team about alcohol, non-prescribed substances and prescribed medicines used differently from the instructions. Ask how mood treatment and substance-use care will be coordinated. Do not assume that an antidepressant treats every consequence of drinking or that addressing alcohol use makes assessment of depression unnecessary.
NICE advises against routinely using antidepressants for alcohol misuse alone. This is different from treating a co-occurring depressive disorder. A plan should state which concern each treatment targets and how changes will be reviewed. Where withdrawal is a concern, assessment of the necessary medical support is separate from selecting an antidepressant. [3]
Continuing treatment after improvement
Feeling better is an important point for review, not an automatic instruction to stop. Discuss the stability of improvement, previous episodes, current stresses, unwanted effects and the reasons for continuing or reconsidering treatment. Ask when the next review should happen even if no immediate change is proposed.
During a transition between providers, confirm responsibility for prescriptions and follow-up. Bring the medicine name, formulation, actual pattern of use and a short summary of progress. Our follow-up coordination guide can help organize that handover. Avoid leaving repeat prescribing uncertain until the last available tablets.
Stopping, switching and withdrawal
Withdrawal symptoms can occur after reducing or stopping an antidepressant. They may resemble depression or anxiety but can also feel different from previous symptoms. A planned reduction should be individualized and reviewed rather than copied from someone else’s experience. Withdrawal is not evidence by itself that the original illness has returned. [4]
Before a change, ask how the prescriber will assess new symptoms and what to do if the plan becomes difficult to follow. A switch between medicines is not a simple substitution of equal numbers of tablets. Keep written instructions and contact details available, particularly during travel or periods when ordinary appointments are harder to obtain.
Preparing for a useful medication appointment
Bring a list of current medicines and supplements, previous treatments and the three questions most important to you. Explain what has improved as carefully as what worries you. Ask for clarification of unfamiliar terms and repeat back the agreed next step. The medication-review checklist provides a practical starting point.
When a proposed treatment does not fit your daily life, say so. Difficulty swallowing, remembering instructions, paying for repeat supplies or attending monitoring can change whether a plan is workable. These are care-planning issues, not evidence that you do not want to recover. The appointment should end with responsibilities and the next contact point clear.
Frequently asked questions
Does everyone with depression need medication?
No. Treatment depends on assessment, severity, previous care and preferences. Psychological treatment, medication and other approaches have different roles.
Does a prescription mean I need residential care?
No. A medicine name cannot establish the appropriate treatment setting. That requires a separate assessment of current needs and available support.
Can a comparison guide choose my antidepressant?
No. It can organize the differences and questions worth discussing, but it does not know your treatment history or full interaction profile.
What matters most at review?
Whether the intended benefit is occurring, what unwanted effects or risks are present, and whether the next step is clearly agreed and supported.
